by GSK for a nasal flu shot in the SARS pandemic hysteria. RVX 208 is the only drug that can reduce cholesterol transport. Phase 2 b trial took place IMMEDIATELY after Phase 2A, this is indicative of strong belief in management that the drug would hold up in the longer trial. I gotta feel that with big pharma at multi year highs this is looking like a multi bagger. Only one analyst following this stock?????? Not on any one's radar. This reminds me of ITP.TO.